News & Updates
Filter by Specialty:
MS patients on certain DMTs may have limited protection from COVID-19 vax
The overall rate of hospitalization for COVID-19 is low among patients with multiple sclerosis (MS) treated with disease-modifying therapies (DMTs) who have been vaccinated against COVID-19, according to a prospective study from England. However, patients on ocrelizumab or fingolimod have elevated hospitalization rates.
MS patients on certain DMTs may have limited protection from COVID-19 vax
30 May 2022
Singe sensor on foot sole predicts gait freezing in Parkinson’s disease
A single plantar pressure sensor device, when placed on the least affected side (LAS), helps predict freezing of gait (FOG) in patients with Parkinson’s disease (PD), according to a recent study.
Singe sensor on foot sole predicts gait freezing in Parkinson’s disease
26 May 2022
Keto diet: Is there good evidence in MS?
A diet rich in fat but low in carbohydrates, popularly known as the ketogenic or “keto” diet, offers clinical benefits to patients with relapsing multiple sclerosis (MS) in a phase II study. Quality of life (QoL) likewise improved, and so did disability.
Keto diet: Is there good evidence in MS?
23 May 2022
Subjective cognitive decline a red flag for Alzheimer’s disease
Subjective cognitive decline appears to be indicative of stage 2 Alzheimer’s disease, where individuals exhibit mild changes in mood or behaviour and subtle objective cognitive decline although not to the point of meeting mild cognitive impairment criteria, as suggested in a study.